|2025年3月26日 星期三|NO.1药明生物营收同比增长9.6%药明生物发布2024年财报。报告期内,公司营收186.8亿元,比上年同期增长9.6%;净利润33.6亿元,比上年同期下降1.3%。点评:药明生物2024年财报显示营收稳健增长,但净利润微降1.3%,呈现增收不增利态势。营收增长印证了全球生物药研发外包需求持续,公司市场份额稳固;而利润下滑可能反映成本上升或项目阶段性投入增加。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.